Sunshine Biopharma (SBFM) Goodwill & Intangibles (2015 - 2026)

Sunshine Biopharma (SBFM) has 9 years of Goodwill & Intangibles data on file, last reported at $1.9 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 39.94% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 39.94% YoY) and the FY2025 annual result came in at $1.9 million, down 37.43% from the prior year.
• Goodwill & Intangibles improved to $1.9 million in Q1 2026, from $1.9 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $3.2 million in Q1 2025 to a low of $776856.0 in Q4 2022.
• A 5-year average of $2.0 million and a median of $2.0 million in 2025 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles soared 141.96% — and 2026, when it sank 39.94%.
• Tracing SBFM's Goodwill & Intangibles over 5 years: stood at $776856.0 in 2022, then soared by 85.91% to $1.4 million in 2023, then surged by 109.08% to $3.0 million in 2024, then plunged by 37.43% to $1.9 million in 2025, then gained by 1.51% to $1.9 million in 2026.
• The last three Goodwill & Intangibles figures came in at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.